Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting, 64734-64735 [2010-26387]
Download as PDF
<![CDATA[
64734
Federal Register / Vol. 75, No. 202 / Wednesday, October 20, 2010 / Notices
Dated: October 14, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
and Research Support Awards, National
Institutes of Health, HHS)
Dated: October 7, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–26390 Filed 10–19–10; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2010–26361 Filed 10–19–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Meeting
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
emcdonald on DSK2BSOYB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
H—Clinical Groups, NCI–H Cooperative
Groups.
Date: November 1, 2010.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6116
Executive Boulevard, Rockville, MD 20852,
(Telephone Conference Call)
Contact Person: Timothy C. Meeker, MD,
PhD, Scientific Review Officer, Resources
and Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Boulevard, Room
8103, Bethesda, MD 20892, (301) 594–1279,
meekert@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to scheduling
conflicts.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
VerDate Mar<15>2010
17:17 Oct 19, 2010
Jkt 223001
Notice is hereby given of a Services
Workshop convened by the Interagency
Autism Coordinating Committee (IACC),
Services Subcommittee.
The purpose of the IACC Services
Workshop: Building a Seamless System
of Quality Services and Supports Across
the Lifespan is to gather State agency
officials and disability experts to
describe solutions and innovations to
systems that result in services, supports,
and policies that help people with
disabilities, including Autism Spectrum
Disorders (ASD), to improve the quality
of their lives across the lifespan.
Name of Committee: Interagency Autism
Coordinating Committee (IACC).
Type of meeting: Services Workshop.
Date: November 8, 2010.
Time: 9 a.m. to 5:30 p.m. Eastern Time.
Agenda: The workshop will focus on
policy issues related to the system of services
and supports for people with ASD and their
families.
Place: Hilton Washington DC/Rockville
Hotel & Executive Meeting Center, 1750
Rockville Pike, Rockville, MD 20852.
Webcast Live: https://videocast.nih.gov/.
Conference Call Access: Phone number:
888–577–8995. Access code: 1991506.
Cost: The meeting is free and open to the
public.
Registration: https://
www.acclaroresearch.com/oarc/11-8-10/.
Online pre-registration is strongly
recommended to expedite check-in.
Access: Metro accessible—Red Line—
Twinbrook Metro Station Hotel parking
validation available.
Contact Person: Ms. Lina Perez, Office of
Autism Research Coordination, Office of the
Director, National Institute of Mental Health,
NIH, 6001 Executive Boulevard, NSC, Room
8185a, Bethesda, MD 20892–9669, Phone:
301–443–6040, E-mail:
IACCPublicInquiries@mail.nih.gov.
The meeting will be open to the public
with attendance limited to space available.
Seats in the meeting room will be on a first
come, first served basis. The meeting will
also be open to the public through a
conference call phone number and webcast
live on the Internet. Members of the public
who participate using the conference call
phone number will be able to listen to the
meeting but will not be heard. If you
experience any technical problems with the
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
webcast live or conference call, please e-mail
IACCTechSupport@acclaroresearch.com.
Individuals who participate in person or by
using these electronic services and who need
special assistance, such as captioning of the
conference call or other reasonable
accommodations, should submit a request to
the Contact Person listed on this notice at
least 7 days prior to the meeting.
To access the webcast live on the Internet
the following computer capabilities are
required: (A) Internet Explorer 5.0 or later,
Netscape Navigator 6.0 or later or Mozilla
Firefox 1.0 or later; (B) Windows® 2000, XP
Home, XP Pro, 2003 Server or Vista; (C)
Stable 56k, cable modem, ISDN, DSL or
better Internet connection; (D) Minimum of
Pentium 400 with 256 MB of RAM
(Recommended); (E) Java Virtual Machine
enabled (Recommended).
Information about the IACC is available on
the Web site: https://www.iacc.hhs.gov.
The schedule for the meeting is subject to
change.
Dated: October 14, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–26389 Filed 10–19–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Maternal Fetal
Medicine Units Network.
Date: November 2, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Legacy Hotel and Meeting Center,
1775 Rockville Pike, Rockville, MD 20852.
Contact Person: Peter Zelazowski, PhD,
Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
E:\FR\FM\20OCN1.SGM
20OCN1
Federal Register / Vol. 75, No. 202 / Wednesday, October 20, 2010 / Notices
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Boulevard, Room 5B01, Bethesda, MD
20892–7510, 301–435–6902,
peter.zelazowski@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: October 14, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–26387 Filed 10–19–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
emcdonald on DSK2BSOYB1PROD with NOTICES
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee.
TIME AND DATE: 9 a.m.–5 p.m., November
8, 2010.
PLACE: Cincinnati Airport Marriott, 2395
Progress Drive, Hebron, Kentucky
41018, Telephone (859) 334–4611, Fax
(859) 334–4619.
Status: Open to the public, but
without a public comment period. To
access by conference call dial the
following information: 1 (866) 659–
0537, Participant Pass Code 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction which
have also been promulgated by HHS as
VerDate Mar<15>2010
17:17 Oct 19, 2010
Jkt 223001
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
and will expire on August 3, 2011.
Purpose: The Advisory Board is
charged with (a) Providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class. The
Subcommittee for Dose Reconstruction
Reviews was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters to be Discussed: The agenda
for the Subcommittee meeting includes:
Selection of individual radiation dose
reconstruction cases to be considered
for review by the Advisory Board;
selection of individual radiation dose
reconstruction cases to be considered
for review by the Procedures
Subcommittee for the evaluation of
Program Evaluation Reports; discussion
of dose reconstruction cases under
review (sets 7–9); OCAS dose
reconstruction quality management and
assurance activities.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
submitted. Any written comments
received will be provided at the meeting
and should be submitted to the contact
person below well in advance of the
meeting.
CONTACT PERSON FOR MORE INFORMATION:
Theodore Katz, Executive Secretary,
NIOSH, CDC, 1600 Clifton Road, NE.,
Mailstop E–20, Atlanta, Georgia 30333,
Telephone (513) 533–6800, Toll Free 1
(800) CDC–INFO, E-mail ocas@cdc.gov.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
64735
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: October 13, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–26368 Filed 10–19–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Cell Biology
and Signaling of Neurodevelopment.
Date: November 4, 2010.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call.)
Contact Person: Laurent Taupenot, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4811,
MSC 7850, Bethesda, MD 20892, 301–435–
1203, taupenol@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Experimental Cancer Therapeutics.
Date: November 15–16, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road, NW.,
Washington, DC 20015.
E:\FR\FM\20OCN1.SGM
20OCN1
]]>Agencies
[Federal Register Volume 75, Number 202 (Wednesday, October 20, 2010)]
[Notices]
[Pages 64734-64735]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-26387]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Child Health and Human
Development Special Emphasis Panel, Maternal Fetal Medicine Units
Network.
Date: November 2, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike,
Rockville, MD 20852.
Contact Person: Peter Zelazowski, PhD, Scientific Review
Officer, Division of Scientific Review, Eunice Kennedy Shriver
[[Page 64735]]
National Institute of Child Health and Human Development, NIH, 6100
Executive Boulevard, Room 5B01, Bethesda, MD 20892-7510, 301-435-
6902, peter.zelazowski@nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: October 14, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-26387 Filed 10-19-10; 8:45 am]
BILLING CODE 4140-01-P
